# Reducing Elevated Heart Rate in Patients With Multiple Organ Dysfunction Syndrome (MODS) by Ivabradine

> **NCT01186783** · PHASE2 · UNKNOWN · sponsor: **Martin-Luther-Universität Halle-Wittenberg** · enrollment: 70 (estimated)

## Conditions studied

- Multiple Organ Dysfunction Syndrome

## Interventions

- **DRUG:** ivabradine

## Key facts

- **NCT ID:** NCT01186783
- **Lead sponsor:** Martin-Luther-Universität Halle-Wittenberg
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-05
- **Primary completion:** 2011-11
- **Final completion:** 2012-05
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2010-09-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01186783

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01186783, "Reducing Elevated Heart Rate in Patients With Multiple Organ Dysfunction Syndrome (MODS) by Ivabradine". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01186783. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*